CellinCells

Pre-Approval PRO BETA

Total Trials

Phase 3

Phase 2

Recruiting

Score

Pipeline by Phase

Phase 3

Phase 2

Phase 1

Atrophic Scar

NCT07474467 Phase 1 NOT YET RECRUITING

Safety and Efficacy of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

Started: 8/1/2026

NCT06210919 Phase 1 COMPLETED

Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars

Started: 12/6/2023

TRTP-101 Placebo

Activity Status: Active

Last Trial Started: 8/1/2026

Last Trial Ended: 3/28/2025

Trials (12 months): 1

Completed Trials: 1

Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.